Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease. [electronic resource]
Producer: 20131115Description: 311-9 p. digitalISSN:- 1502-7708
- Adalimumab
- Adolescent
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Crohn Disease -- drug therapy
- Cytokines -- genetics
- Female
- Follow-Up Studies
- Gene Expression
- Humans
- Infliximab
- Intestinal Mucosa -- metabolism
- Male
- Middle Aged
- RNA, Messenger -- metabolism
- Recurrence
- Remission Induction
- Sensitivity and Specificity
- Time Factors
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Withholding Treatment
- Young Adult
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.